Zoonotic Disease Research Program Shut Down

The USAID’s Predict program, which conducted animal virus surveillance and disease outbreak prevention training, is ending after its 10-year funding run.

Written byEmily Makowski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Predict, an animal virus surveillance program run by the United States Agency for International Development, is shutting down after 10 years of research, according to The New York Times. Launched after an H5N1 bird flu outbreak, Predict was part of an effort to search for previously undiscovered zoonotic diseases, which are passed from animals to humans. Viruses such as AIDS, SARS, MERS, Ebola, and certain influenza strains originally came from animals.

Researchers found more than 1,000 new viruses from animal samples collected during the program’s run, including a new Ebola strain. In addition, it provided disease outbreak prevention training for thousands of people and strengthened medical laboratories in developing countries.

The program, which partnered with universities, conservation groups, and nonprofits to track, monitor, and prevent disease, was shut down at the end of its 10-year funding cycle. Some public health officials worry that its end could leave the world more ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies